Form 8-A12B

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-A

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR 12(g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

BIOMERICA, INC.

(Exact Name of Registrant as Specified in its Charter)

 


 Delaware

000-08765

 95-2645573

 (State or Other Jurisdiction of

 (Commission File Number)

 (IRS Employer

 Incorporation or Organization)  

 

 Identification No.)

 

17571 Von Karman Avenue

Irvine, CA 92614

 (Address of principal executive offices) (Zip Code)

 



Securities to be registered pursuant to Section 12(b) of the Act:  

 

Title of each class to be registered:  Common Stock, par value $0.08 per share

 

Name of each exchange on which each class is to be registered:  The NASDAQ Stock Market LLC

 

If this Form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box. x

 

If this Form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box. ¨

 

Securities Act registration statement file number to which this form relates: None

 

Securities to be registered pursuant to Section 12(g) of the Act: None.

 



 

Item 1.    Description of Registrant's Securities to be Registered.


The description of the common stock of Biomerica, Inc. (the “Registrant”), as included under the caption “Description of Securities” in the prospectus forming a part of the Registration Statement on Form SB-2 (Registration No. 333-87231) (the “Registration Statement”), filed under the Securities Act of 1933, as amended (the “Securities Act”), is incorporated by reference herein.


Item 2.    Exhibits.


Under the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.





 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

 

BIOMERICA, INC.

 

 

 

 

 

 

 

 

 

 

 

 

 

Date:  August 23, 2016

By:

/s/ Zackary S. Irani

 

 

 

Name: Zackary S. Irani

 

 

 

Title:   Chief Executive Officer